当代泌尿学(英文)(Current Urology)(2024年12月31日之前不收版面费审稿费) 知网目次
- 国级普刊
- 主管单位:
教育部
- 主办单位:
山东大学
- 国际刊号:
1661-7649;ISSN 1661-7657
- 国内刊号:
37-1543/R4
- 学科分类:
- 字数:
-
- 有无基金:
- 周期:
CN外文-季刊
- 特殊属性:
外文期刊
- 电话:
0531-85875737
- 邮箱:
current_urology@hotmail.comcurrent_urology@sdu.edu.cn(官网邮箱)
- 复合因子:
0
- 综合因子:
0
- 收录:
知网目次
- 级别:
国级普刊
期刊简介
《当代泌尿学(英文)(Current Urology)(2024年12月31日之前不收版面费审稿费)》期刊已被查看: 次
更新频次
单位占比
一作占比
投稿指南
1、投稿方式:在线投稿。
2、刊内网址:http://www.currurol.org(202302期)
自动跳转至:
https://journals.lww.com/cur/pages/default.aspx
3、投稿系统:
https://www.editorialmanager.com/curr-urol
4、山东大学期刊社:http://njournal.sdu.edu.cn/
5、出刊日期:季刊,逢季末月出版。
6、2024年12月31日之前投稿免收文章处理费。
(微信公众号“current_urology”信息)
2023年9月5星期二
Current Urology获批国家统一连续出版物号(CN号)
【微信公众号信息】
原创 获得CN号的 Current Urology 2023-08-17
近日,国家新闻出版署批复,《当代泌尿学 (英文)》(Current Urology, CU)获国内统一连续出版物号CN 37-1543/R4,各项指标稳步提升,前景可期。
该刊由教育部主管,山东大学主办,山大科技期刊社与荷兰Wolters Kluwer(威科)集团合作出版,山东大学第二医院承办,旨在为全球泌尿外科学者和专家搭建一流的学术交流平台,着力解决当代泌尿外科领域前沿热点与难点问题。
Current Urology(《当代泌尿学(英文)》)2020年入选山东大学“强刊兴学”计划,2022年入选首批中国机构主办海外科技期刊回归试点期刊,参照中国科技期刊卓越行动计划高起点新刊支持力度,并纳入卓越行动计划统筹管理,现已被Emerging Sources Citations Index (ESCI), PubMed, PubMed Central, Scopus, Ovid, DOAJ, Embase, Chemical Abstract Service(CAS)等20余家数据库收录。2023年6月,获得首个影响因子(Impact Factor):1.6分,达到JCR Q3区。
杂志由中国工程院郭应禄院士、瑞典前泌尿外科主席Peter Ekman教授担任共同主编,上海交通大学附属上海市第一人民医院夏术阶教授、山东大学第二医院唐东起教授担任共同执行主编,山东大学易凡教授、海口市人民医院白志明教授、山东省立医院吕家驹教授、北京大学第一医院李学松教授等担任副主编。由45名来自世界10多个国家和地区的高影响力学者组成国际化编委会,并组建起拥有22名学者的青年编委团队,旨在为全球泌尿外科学者和专家搭建一流的学术交流平台,着力解决当代泌尿外科领域前沿热点与难点问题。
该刊发表论文类型包括Original articles(原创论著), Reviews(综述), Case reports(病例报告), Commentaries(评论), Editorials(社论), Consensuses and Guidelines(共识与指南), Perspectives(观点), Letters(通讯)等。文章一经接收,将在Lippincott平台在线快速发表。
自创刊以来,期刊共收到来自57个国家和地区的2000余篇稿件,稿源丰富,国际化程度高,其中投稿最多的前两位为美国(17.5%)和英国(13.1%)。期刊的拒稿率在70%以上,保证了发表文章的学术质量。杂志聚焦泌尿系肿瘤、泌尿系结石、COVID-19 and Urology等热点方向组织多期专题并通过各种形式大力宣传,大大提升了文章的国际影响力,其中单篇文章最高访问量8000余次。
作为泌尿学领域的国际学术期刊,Current Urology获批国家统一连续出版物号,将为国内外泌尿领域学者专家提供更广阔的交流平台,进一步提升我国在全球泌尿外科领域的国际影响力,为我国医学科学领域高水平科技自立自强提供支撑。
关于我们
期刊简介
Current Urology 是一本专业的泌尿外科全英文期刊,由山东大学主办,山大科技期刊社与荷兰Wolters Kluwer(威科)集团合作出版,山东大学第二医院承办。目前期刊已入选教育部首批海外回归试点期刊,并被ESCI, PubMed, Scopus, DOAJ等国际数据库收录。
期刊为OA出版,2024年12月31日之前投稿免收文章处理费。
栏目设置:
原创研究、综述、手术技术、病例报道、述评等
文章范围包括但不限于:
泌尿学基础研究、肿瘤研究、外科手术、影像学、病理学、尿石症、男科学、小儿泌尿外科、女性泌尿外科、尿流动力学、性功能障碍、男性不育症、腔内泌尿外科和移植,以及材料、微能量、大数据、人工智能、再生医学等在泌尿领域的应用。
联系我们:current_urology@hotmail.com; current_urology@sdu.edu.cn
《当代泌尿学(英文)》作者须知
【官网信息】
Instructions for Authors
The Editorial Office is pleased to answer any questions you may have about preparing your manuscript in accordance with our guidelines.
Email: current_urology@hotmail.com
AIMS AND SCOPE
Current Urology is an international peer-reviewed journal providing practical, timely, and state-of-the-art contributions on clinical research and experience in urology.
The journal encompasses all aspects of basic urological research, clinical diagnosis, surgical and medical oncology, radiology, pathology, urolithiasis, andrology, reconstruction surgery, pediatric urology, female urology and urodynamics, erectile dysfunction, infertility, urinary infections and inflammations, endourology, and transplantation. Each issue contains reviews, original articles, methodology articles, case reports, commentaries and Letter to the Editor. It is published online.
Urologists, oncologists, pathologists, radiologists and scientists are invited to hand in their contributions to make Current Urology a viable international forum on latest findings in research and practice in urology.
ONLINE SUBMISSION
All manuscripts must be submitted online at: https://www.editorialmanager.com/curr-urol/
First-time Users
Please click the Register button at https://www.editorialmanager.com/curr-urol/ Upon successful registration, you will be sent an email providing your username and password. Save this information for future reference. Note: If you have received an email from us with an assigned username and password, or if you are a repeat user, do not register again. Once you have an assigned username and password, you do not have to re-register.
Authors
Please click the Login button from the menu at the top of the page and login to the system as an author. Submit your manuscript according to the author instructions. You will be able to track the process of your manuscript through the system.
JOURNAL POLICIES
Duplicate Publication
Manuscripts are reviewed for possible publication with the understanding that they are being submitted only to the Current Urology and have not been published, simultaneously submitted, or already accepted for publication elsewhere. The Editorial team may subject any manuscript submitted for consideration of publication in Current Urology to plagiarism-detection software.
This does not preclude consideration of a manuscript that has been rejected by another journal or a complete report that follows publication of preliminary findings elsewhere, usually in the form of an abstract. Copies of any possibly duplicate published material should be submitted with the manuscript under consideration, with a statement in the cover letter as to why the manuscript currently being submitted is not a duplicate publication.
Disclosure of Conflicts
Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript. All relevant conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading "Conflicts of Interest and Source of Funding:". For example: “Conflicts of Interest and Source of Funding: A has received honoraria from Company Z. B is currently receiving a grant (#12345) from Organization Y, and is on the speaker's bureau for Organization X - the CME organizers for Company A. For the remaining authors none were declared."
Authorship
Current Urology expects that each person listed as an author has participated sufficiently in the intellectual content, the analysis of data, and/or the writing of the manuscript to take public responsibility for it. Each author must have reviewed the manuscript, believes it represents valid work, and approves it for submission.
Moreover, should the Editorial team request the data upon which the manuscript is based, the authors shall produce it. Each author's specific contributions to the work should be indicated; this information will be published as a footnote to the paper. For example, the areas of participation might include:
Participated in research design
Participated in the writing of the paper
Participated in the performance of the research
Contributed new reagents or analytic tools
Participated in data analysis
An author may list more than one contribution, and more than one author may have contributed to the same aspect of the work. Any change in authorship/contributions after submission must be approved in writing by all authors and submitted to the Editorial Office for final consideration.
English Language Assistance
Appropriate use of the English language is a requirement for publication in Current Urology. Authors who have difficulty in writing in English who submit manuscripts to international journals often receive negative comments from referees or editors about the English-language usage in their manuscripts, and these challenges can contribute to a decision to reject a paper. To help reduce the possibility of such problems, we strongly encourage such authors consider using Wolters Kluwer Author Services**.
……
更多详情:
https://journals.lww.com/cur/Pages/Instructions-for-Authors.aspx
中国全科医学发文选摘
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
《当代泌尿学(英文)(Current Urology)(2024年12月31日之前不收版面费审稿费)》同类外科学期刊
-
中华消化外科杂志
北核,CSCD,科核,武A+,高T2
CN中文-月刊影响因子2.781
-
中华显微外科杂志
北核,CSCD,武A-
CN中文-双月刊影响因子1.939
-
中华骨质疏松和骨矿盐疾病杂志
北核,CSCD,科核,武A,高T3
CN中文-双月刊影响因子1.349
-
中华胸心血管外科杂志
CSCD,科核,高T2
CN中文-月刊影响因子0.752
-
中华手外科杂志
北核,CSCD,科核
CN中文-双月刊影响因子1.035
-
中国胸心血管外科临床杂志
北核,科核,CSCD扩,武B+,CACJ-扩展
CN中文-月刊影响因子0.936
-
中华外科杂志
北核,CSCD,科核,武A+
CN中文-月刊影响因子1.358
-
中华烧伤与创面修复杂志(原:中华烧伤杂志)
北核,CSCD,科核,武A,高T1,高T2
CN中文-月刊影响因子1.581
常见问题
-
哪些期刊可以用来评职称?
1、期刊要具备正规性和合法性,需在国家新闻出版总署备案,具备国内刊号(cn)。2、期刊要具备学术性,例如该期刊需被国内主流学术、数据库收录,例如被知网,万方,维普收录。具体详情可以咨询我们的客服老师为您解答。
-
你们的服务可以保证文章被发表吗?
期刊发表的成功与否,主要取决于文章内容的质量。期刊编辑会根据研究领域、创新性等多因素进行考量。我们会帮助您理解期刊的发表要求,助力提升发表几率,从而增加发表的机会。
-
请问发表一篇期刊的费用是多少?
期刊的种类繁多,其费用也各不相同。根据您的需求,将为您推荐最具性价比的期刊,让您能更便捷地找到心仪的期刊。一般来说,只要符合职称评定要求的,大多数作者都会选择性价比最高的期刊作为首选目标。
-
如果发表不成功可以退款吗?
如果因为我方原因导致未能发表成功,我们将全额退还相关费用。需要明确的是,稿件能否发表主要取决于期刊的独立考量。为了提升您的发表几率,我们会提供专业的指导和支持,帮助您避免拒稿,并助力提高您的稿件质量。
-
请问文章发表需要多长时间?
不同级别的期刊发表时间是不一样的。无论是普刊还是核心期刊,建议您提前准备。普刊需提前3-6个月,而核心期刊需提前一年左右。为确保职称评定流程顺利进行,建议您提前半年到一年进行准备,以免错过申请的最佳时机。
-
期刊发表能加急见刊吗?
为了确保顺利发表,建议您提前一些时间进行安排。本站仅提供投稿发表咨询服务,需要用户自己向出版商投稿且没有绿色通道,是否录用一切以出版商通知为准。